The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Singh, A., Dilnawaz, F., Mewar, S., Sharma, U., Jagannathan, N. R., & Sahoo, S. K. (2011) · ACS Applied Materials & Interfaces · doi:10.1021/am101196v · Cited by 161
RetractedLipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
REJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,864
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Self-citationMechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
Cationic liposome-mediated transfection
Felgner, P. L., & Ringold, G. M. (1989) · Nature · doi:10.1038/337387a0 · Cited by 987
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 945
Meng, H., Liong, M., Xia, T., Li, Z., Ji, Z., Zink, J. I., & Nel, A. E. (2010) · ACS Nano · doi:10.1021/nn100690m · Cited by 902
Chen, A. M., Zhang, M., Wei, D., Stueber, D., Taratula, O., Minko, T., & He, H. (2009) · Small · doi:10.1002/smll.200900621 · Cited by 671
Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent
Liu, L., Xu, K., Wang, H., Jeremy Tan, P. K., Fan, W., Venkatraman, S. S., Li, L., & Yang, Y.-Y. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.153 · Cited by 670
Wang, Y., Gao, S., Ye, W.-H., Yoon, H. S., & Yang, Y.-Y. (2006) · Nature Materials · doi:10.1038/nmat1737 · Cited by 658
Kolishetti, N., Dhar, S., Valencia, P. M., Lin, L. Q., Karnik, R., Lippard, S. J., Langer, R., & Farokhzad, O. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011368107 · Cited by 565
Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
Shapira, A., Livney, Y. D., Broxterman, H. J., & Assaraf, Y. G. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.01.003 · Cited by 504
Ganta, S., & Amiji, M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800240j · Cited by 490
Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.
Shah, M. A., & Schwartz, G. K. (2001) · PubMed · Cited by 450
Polymer-drug conjugates: Recent development in clinical oncology
Li, C., & Wallace, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.009 · Cited by 436
Devita, V. T., Young, R. C., & Canellos, G. P. (1975) · Cancer · doi:10.1002/1097-0142(197501)35:1<98::aid-cncr2820350115>3.0.co;2-b · Cited by 411
Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy
Dilnawaz, F., Singh, A., Mohanty, C., & Sahoo, S. K. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.057 · Cited by 385
Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer
Saad, M., Garbuzenko, O. B., & Minko, T. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.761 · Cited by 367
Tardi, P., Johnstone, S., Harasym, N., Xie, S., Harasym, T., Zisman, N., Harvie, P., Bermudes, D., & Mayer, L. (2009) · Leukemia Research · doi:10.1016/j.leukres.2008.06.028 · Cited by 356
Delbaldo, C., Michiels, S., Syz, N., Soria, J.-C., Le Chevalier, T., & Pignon, J.-P. (2004) · JAMA · doi:10.1001/jama.292.4.470 · Cited by 337
Patil, Y., Sadhukha, T., Ma, L., & Panyam, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.021 · Cited by 317
Feldman, E. J., Lancet, J. E., Kolitz, J. E., Ritchie, E. K., Roboz, G. J., List, A. F., Allen, S. L., Asatiani, E., Mayer, L. D., Swenson, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5961 · Cited by 310
Patil, Y. B., Swaminathan, S. K., Sadhukha, T., Ma, L., & Panyam, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.048 · Cited by 304
Patel, N. M., Nozaki, S., Shortle, N. H., Bhat-Nakshatri, P., Newton, T. R., Rice, S., Gelfanov, V., Boswell, S. H., Goulet, R. J., Sledge, G. W., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203768 · Cited by 294
Gao, S., Dagnaes-Hansen, F., Nielsen, E. J. B., Wengel, J., Besenbacher, F., Howard, K. A., & Kjems, J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.91 · Cited by 286
Emilienne Soma, C., Dubernet, C., Bentolila, D., Benita, S., & Couvreur, P. (2000) · Biomaterials · doi:10.1016/s0142-9612(99)00125-8 · Cited by 281
Biofunctionalized targeted nanoparticles for therapeutic applications
Wang, A. Z., Gu, F., Zhang, L., Chan, J. M., Radovic-Moreno, A., Shaikh, M. R., & Farokhzad, O. C. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.8.1063 · Cited by 270
Self-citationCo‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates
Zhang, L., Radovic‐Moreno, A. F., Alexis, F., Gu, F. X., Basto, P. A., Bagalkot, V., Jon, S., Langer, R. S., & Farokhzad, O. C. (2007) · ChemMedChem · doi:10.1002/cmdc.200700121 · Cited by 257
Self-citationDevelopment of Novel Combination Therapies
Woodcock, J., Griffin, J. P., & Behrman, R. E. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1101548 · Cited by 248
Lammers, T., Subr, V., Ulbrich, K., Peschke, P., Huber, P. E., Hennink, W. E., & Storm, G. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.040 · Cited by 240
Misra, R., & Sahoo, S. K. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100455h · Cited by 232
Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance.
Bradshaw, D. M., & Arceci, R. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3674 · Cited by 223
Therapeutic Nanoparticles to Combat Cancer Drug Resistance
Hu, C.-M., & Zhang, L. (2009) · Current Drug Metabolism · doi:10.2174/138920009790274540 · Cited by 223
Self-citationvan Vlerken, L. E., Duan, Z., Seiden, M. V., & Amiji, M. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1648 · Cited by 214
Batist, G., Gelmon, K. A., Chi, K. N., Miller, W. H., Chia, S. K. L., Mayer, L. D., Swenson, C. E., Janoff, A. S., & Louie, A. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0515 · Cited by 213
Hu, C.-M. J., Kaushal, S., Cao, H. S. T., Aryal, S., Sartor, M., Esener, S., Bouvet, M., & Zhang, L. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900316a · Cited by 212
Self-citationSong, X. R., Cai, Z., Zheng, Y., He, G., Cui, F. Y., Gong, D. Q., Hou, S. X., Xiong, S. J., Lei, X. J., & Wei, Y. Q. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.018 · Cited by 211
A primer on the mechanics of P-glycoprotein the multidrug transporter
Hennessy, M., & Spiers, J. P. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2006.10.007 · Cited by 199
Polymeric Nanoparticles with Precise Ratiometric Control over Drug Loading for Combination Therapy
Aryal, S., Hu, C.-M. J., & Zhang, L. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200243k · Cited by 198
Self-citationFunctional expression and localization of P‐glycoprotein at the blood brain barrier
Bendayan, R., Lee, G., & Bendayan, M. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10090 · Cited by 187
Kaneshiro, T. L., & Lu, Z.-R. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.026 · Cited by 186
Combinatorial Drug Conjugation Enables Nanoparticle Dual‐Drug Delivery
Aryal, S., Hu, C. J., & Zhang, L. (2010) · Small · doi:10.1002/smll.201000631 · Cited by 183
Self-citationDrug-Polymer Conjugates Containing Acid-Cleavable Bonds
Kratz, F., Beyer, U., & Schutte, M. T. (1999) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v16.i3.10 · Cited by 181
Di Maio, M., Chiodini, P., Georgoulias, V., Hatzidaki, D., Takeda, K., Wachters, F. M., Gebbia, V., Smit, E. F., Morabito, A., Gallo, C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5844 · Cited by 181
Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics
Tekade, R. K., Dutta, T., Gajbhiye, V., & Jain, N. K. (2009) · Journal of Microencapsulation · doi:10.1080/02652040802312572 · Cited by 181
Patel, N. R., Rathi, A., Mongayt, D., & Torchilin, V. P. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.082 · Cited by 173
Wu, J. H., Lu, Y., Lee, A., Pan, X., Yang, X., Zhao, X. B., & Lee, R. J. (2007) · PubMed · Cited by 172
Cyclosporine A and adverse effects on organs: histochemical studies
Rezzani, R. (2004) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2004.04.001 · Cited by 170
Lim, W.-S., Tardi, P. G., Dos Santos, N., Xie, X., Fan, M., Liboiron, B. D., Huang, X., Harasym, T. O., Bermudes, D., & Mayer, L. D. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.01.015 · Cited by 164
Size of IgG-Opsonized Particles Determines Macrophage Response during Internalization
Koval, M., Preiter, K., Adles, C., Stahl, P. D., & Steinberg, T. H. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4110 · Cited by 163
Fan, L., Li, F., Zhang, H., Wang, Y., Cheng, C., Li, X., Gu, C., Yang, Q., Wu, H., & Zhang, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.066 · Cited by 155
A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs
Shin, H.-C., Alani, A. W. G., Cho, H., Bae, Y., Kolesar, J. M., & Kwon, G. S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2000549 · Cited by 126
By-passing of P-glycoprotein Using Immunoliposomes
Huwyler, J., Cerletti, A., Fricker, G., Eberlé, A. N., & Drewe, J. (2002) · Journal of drug targeting · doi:10.1080/10611860290007559 · Cited by 125
Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs
Takakura, Y., & Hashida, M. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00131-c · Cited by 122
Tardi, P. G., Santos, N. D., Harasym, T. O., Johnstone, S. A., Zisman, N., Tsang, A. W., Bermudes, D. G., & Mayer, L. D. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0243 · Cited by 122
Polymer-drug conjugates: current status and future trends
Greco, F., & Vicent, M. J. (2007) · Frontiers in bioscience · doi:10.2741/2882 · Cited by 113
Wang, Z., & Ho, P. C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.075 · Cited by 102
HPMA-based polymer conjugates with drug combination
Krakovičová, H., Etrych, T., & Ulbrich, K. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.03.011 · Cited by 99
Fracasso, P. M., Brady, M. F., Moore, D. H., Walker, J. L., Rose, P. G., Letvak, L. A., Grogan, T. M., & McGuire, W. P. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.12.2975 · Cited by 95
Harasym, T. O., Tardi, P. G., Harasym, N. L., Harvie, P., Johnstone, S. A., & Mayer, L. D. (2006) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/000000006783980937 · Cited by 84
Bebawy, M., & Chetty, M. (2009) · Current Drug Metabolism · doi:10.2174/138920009788498996 · Cited by 83
Advani, R. H., Fisher, G. A., Lum, B. L., Hausdorff, J., Halsey, J., Litchman, M., & Sikic, B. I. (2001) · PubMed · Cited by 81
Cao, X., Yu, L. X., Barbaciru, C., Landowski, C. P., Shin, H., Gibbs, S. T., Miller, H. A., Amidon, G. L., & Sun, D. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0499104 · Cited by 80
Neuroblastoma-targeted Nanoparticles Entrapping siRNA Specifically Knockdown ALK
Paolo, D. D., Brignole, C., Pastorino, F., Carosio, R., Zorzoli, A., Rossi, M., Loi, M., Pagnan, G., Emionite, L., Cilli, M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.54 · Cited by 74
A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA.
Nakamura, K., Lila, A. A., Matsunaga, M., Doi, Y., Ishida, T., & Kiwada, H. (2011) · Molecular Therapy · doi:10.1038/mt.2011.174 · Cited by 64
Pavillard, V., Kherfellah, D., Richard, S., Robert, J., & Montaudon, D. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2027 · Cited by 59
Zhao, L., Cheng, Y., Hu, J., Wu, Q., & Xu, T. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp907437e · Cited by 58
van Vlerken, L. E., Duan, Z., Little, S. R., Seiden, M. V., & Amiji, M. M. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9174-4 · Cited by 57
Strategies to Overcome or Circumvent P-Glycoprotein Mediated Multidrug Resistance
Li, X., Yuan, H., Wu, J., Li, J., Qu, X., Xu, W., & Tang, W. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783503258 · Cited by 57
Chiu, G. N. C., Wong, M.-Y., Ling, L.-U., Shaikh, I. M., Tan, K.-B., Chaudhury, A., & Tan, B.-J. (2009) · Current Drug Metabolism · doi:10.2174/138920009790274531 · Cited by 50
Liang, G., Lü, W.-L., Wu, J., Zhao, J., Hong, H., Long, C., Li, T., Zhang, Y., Zhang, H., Wang, J., et al. (2008) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00613.x · Cited by 41
Pharmacokinetics of CPX-351 (Cytarabine/Daunorubicin HCl) Liposome injection in the mouse
Bayne, W. F., Mayer, L. D., & Swenson, C. E. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21620 · Cited by 40
Li, X., Lu, W., Liang, G., Ruan, G. R., Hong, H., Long, C., Zhang, Y., Liu, Y., Wang, J., Zhang, X., et al. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01643.x · Cited by 32
Cell-Specific Targeting of Lipid-Based Carriers for ODN and DNA
Bartsch, M., Weeke-Klimp, A. H., Meijer, D. K. F., Scherphof, G. L., & Kamps, J. A. A. M. (2005) · Journal of Liposome Research · doi:10.1081/lpr-64961 · Cited by 30
Cited by
Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2
Caesar, L. K., & Cech, N. B. (2019) · Natural Product Reports · doi:10.1039/c9np00011a · Cited by 881
Photosensitizers with Aggregation‐Induced Emission: Materials and Biomedical Applications
Hu, F., Xu, S., & Liu, B. (2018) · Advanced Materials · doi:10.1002/adma.201801350 · Cited by 859
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Markman, J. L., Rekechenetskiy, A., Holler, E., & Ljubimova, J. Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.019 · Cited by 733
“Further, covalent attachment of hydrophobic drugs such as Doxorubicin and Paclitaxel is frequently employed [6,7,10].”
BackgroundRecent advances of cocktail chemotherapy by combination drug delivery systems
Hu, Q., Sun, W., Wang, C., & Gu, Z. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.022 · Cited by 625
Elmowafy, E. M., Tiboni, M., & Soliman, M. E. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00439-x · Cited by 621
Metadata
- Authors
- Hu, C.-M. J., & Zhang, L.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 83
- Issue
- 8
- Pages
- 1104-1111
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2169829820
- Cited by
- 686
- References
- 77
- FWCI
- 18.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.